Literature DB >> 32424043

Molecular mechanism of the recognition of bacterially cleaved immunoglobulin by the immune regulatory receptor LILRA2.

Rika Yamazaki1, Atsushi Furukawa2, Kouyuki Hirayasu3,4,5, Kohei Yumoto1, Hideo Fukuhara6, Hisashi Arase3,4, Katsumi Maenaka2,6,7,8.   

Abstract

Human leukocyte immunoglobulin-like receptors (LILRs) typically regulate immune activation by binding to the human leukocyte antigen class I molecules. LILRA2, a member of the LILR family, was recently reported to bind to other unique ligands, the bacterially degraded Igs (N-truncated Igs), for the activation of immune cells. Therefore, LILRA2 is currently attracting significant attention as a novel innate immune receptor. However, the detailed recognition mechanisms required for this interaction remain unclear. In this study, using several biophysical techniques, we uncovered the molecular mechanism of N-truncated Ig recognition by LILRA2. Surface plasmon resonance analysis disclosed that LILRA2 specifically binds to N-truncated Ig with weak affinity (Kd = 4.8 μm) and fast kinetics. However, immobilized LILRA2 exhibited a significantly enhanced interaction with N-truncated Ig due to avidity effects. This suggests that cell surface-bound LILRA2 rapidly monitors and identifies bi- or multivalent abnormal N-truncated Igs through specific cross-linking to induce immune activation. Van't Hoff analysis revealed that this interaction is enthalpy-driven, with a small entropy loss, and results from differential scanning calorimetry indicated the instability of the putative LILRA2-binding site, the Fab region of the N-truncated Ig. Atomic force microscopy revealed that N truncation does not cause significant structural changes in Ig. Furthermore, mutagenesis analysis identified the hydrophobic region of LILRA2 domain 2 as the N-truncated Ig-binding site, representing a novel ligand-binding site for the LILR family. These results provide detailed insights into the molecular regulation of LILR-mediated immune responses targeting ligands that have been modified by bacteria.
© 2020 Yamazaki et al.

Entities:  

Keywords:  LILRA2; atomic force microscopy (AFM); bacterially cleaved immunoglobulin; cell surface receptor; immune regulation; immune regulatory receptor; immunoglobulin G (IgG); immunology; leukocyte immunoglobulin-like receptor (LILR); protein-protein interaction; surface plasmon resonance (SPR)

Mesh:

Substances:

Year:  2020        PMID: 32424043      PMCID: PMC7363141          DOI: 10.1074/jbc.RA120.013354

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  48 in total

1.  Thermodynamics of T cell receptor binding to peptide-MHC: evidence for a general mechanism of molecular scanning.

Authors:  J J Boniface; Z Reich; D S Lyons; M M Davis
Journal:  Proc Natl Acad Sci U S A       Date:  1999-09-28       Impact factor: 11.205

2.  The human low affinity Fcgamma receptors IIa, IIb, and III bind IgG with fast kinetics and distinct thermodynamic properties.

Authors:  K Maenaka; P A van der Merwe; D I Stuart; E Y Jones; P Sondermann
Journal:  J Biol Chem       Date:  2001-09-05       Impact factor: 5.157

3.  Crystal structure of HLA-A2 bound to LIR-1, a host and viral major histocompatibility complex receptor.

Authors:  Benjamin E Willcox; Leonard M Thomas; Pamela J Bjorkman
Journal:  Nat Immunol       Date:  2003-08-03       Impact factor: 25.606

Review 4.  On the link between conformational changes, ligand binding and heat capacity.

Authors:  S Vega; O Abian; A Velazquez-Campoy
Journal:  Biochim Biophys Acta       Date:  2015-10-22

5.  Biophysical characterization of O-glycosylated CD99 recognition by paired Ig-like type 2 receptors.

Authors:  Shigekazu Tabata; Kimiko Kuroki; Jing Wang; Mizuho Kajikawa; Ikuo Shiratori; Daisuke Kohda; Hisashi Arase; Katsumi Maenaka
Journal:  J Biol Chem       Date:  2008-01-30       Impact factor: 5.157

6.  Structural basis for recognition of the nonclassical MHC molecule HLA-G by the leukocyte Ig-like receptor B2 (LILRB2/LIR2/ILT4/CD85d).

Authors:  Mitsunori Shiroishi; Kimiko Kuroki; Linda Rasubala; Kouhei Tsumoto; Izumi Kumagai; Eiji Kurimoto; Koichi Kato; Daisuke Kohda; Katsumi Maenaka
Journal:  Proc Natl Acad Sci U S A       Date:  2006-10-20       Impact factor: 11.205

Review 7.  Immune checkpoint targeting in cancer therapy: toward combination strategies with curative potential.

Authors:  Padmanee Sharma; James P Allison
Journal:  Cell       Date:  2015-04-09       Impact factor: 41.582

8.  Human inhibitory receptors Ig-like transcript 2 (ILT2) and ILT4 compete with CD8 for MHC class I binding and bind preferentially to HLA-G.

Authors:  Mitsunori Shiroishi; Kouhei Tsumoto; Kimie Amano; Yasuo Shirakihara; Marco Colonna; Veronique M Braud; David S J Allan; Azure Makadzange; Sarah Rowland-Jones; Benjamin Willcox; E Yvonne Jones; P Anton van der Merwe; Izumi Kumagai; Katsumi Maenaka
Journal:  Proc Natl Acad Sci U S A       Date:  2003-07-09       Impact factor: 11.205

9.  MIB-MIP is a mycoplasma system that captures and cleaves immunoglobulin G.

Authors:  Yonathan Arfi; Laetitia Minder; Carmelo Di Primo; Aline Le Roy; Christine Ebel; Laurent Coquet; Stephane Claverol; Sanjay Vashee; Joerg Jores; Alain Blanchard; Pascal Sirand-Pugnet
Journal:  Proc Natl Acad Sci U S A       Date:  2016-04-25       Impact factor: 11.205

10.  Molecular recognition of paired receptors in the immune system.

Authors:  Kimiko Kuroki; Atsushi Furukawa; Katsumi Maenaka
Journal:  Front Microbiol       Date:  2012-12-31       Impact factor: 5.640

View more
  5 in total

1.  The mycoplasma surface proteins MIB and MIP promote the dissociation of the antibody-antigen interaction.

Authors:  Pierre Nottelet; Laure Bataille; Geraldine Gourgues; Robin Anger; Carole Lartigue; Pascal Sirand-Pugnet; Esther Marza; Remi Fronzes; Yonathan Arfi
Journal:  Sci Adv       Date:  2021-03-05       Impact factor: 14.136

Review 2.  Leukocyte Immunoglobulin-Like Receptors in Regulating the Immune Response in Infectious Diseases: A Window of Opportunity to Pathogen Persistence and a Sound Target in Therapeutics.

Authors:  Florence Abdallah; Sixtine Coindre; Margaux Gardet; Florian Meurisse; Abderrahim Naji; Narufumi Suganuma; Laurent Abi-Rached; Olivier Lambotte; Benoit Favier
Journal:  Front Immunol       Date:  2021-09-14       Impact factor: 7.561

Review 3.  Beware of Mycoplasma Anti-immunoglobulin Strategies.

Authors:  Yonathan Arfi; Carole Lartigue; Pascal Sirand-Pugnet; Alain Blanchard
Journal:  mBio       Date:  2021-11-16       Impact factor: 7.867

Review 4.  LILRB4, an immune checkpoint on myeloid cells.

Authors:  Ting Yang; Yixin Qian; Xiaoting Liang; Jianbo Wu; Ming Zou; Mi Deng
Journal:  Blood Sci       Date:  2022-05-17

5.  Integrated analysis of the M2 macrophage-related signature associated with prognosis in ovarian cancer.

Authors:  Caijiao Peng; Licheng Li; Guangxia Luo; Shanmei Tan; Ruming Xia; Lanjuan Zeng
Journal:  Front Oncol       Date:  2022-08-26       Impact factor: 5.738

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.